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Interaction of Chelating Agents with Cadmium
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by Vladislav Eybl,* Jindrich S kora,* Jaroslav Koutenskj,*
Dagmar Caisova,* Alexandr Schwartzt and Frantisek Mertl*
The influence of several chelating agents (CaDTPA, ZnDTPA, CaEDTA, ZnEDTA,
DMSA, D-penicillamine and DMPS, DMP and DDC) on the acute toxicity ofCdCl2 and on
the whole body retention and tissue distribution of cadmium after the IV application of
ll5mCdCl2 was compared in mice. The chelating agents were applied immediately after
the application of cadmium. CaDTPA, ZnDTPA and DMSA appeared to be the most
effective antidotes. However, DMSA increased the amount of cadmium retained in
kidneys. The treatment ofcadmium-poisoned mice with the combination of DMSA (IP)
and ZnDTPA (SC) (all the compounds were injected in equimolar dose) decreased the
toxicity ofcadmium more than treatment with one chelating agents (given in a 2:1 dose).
However, by studying the effect of these chelating agents and their combination of the
retention and distribution ofCd in mice, it was demonstrated that the combined applica-
tion ofthe antidotes showed little or no improvement over the results obtained with the
most effective ofthe individual components. In the urine ofrats injected with CdCl2 and
treated with the chelating agents (CaDTPA, ZnDTPA, DMSA), the presence of cadmium
complexes was demonstrated. The formation of mixed ligand chelates in vivo was not
proved. Experiments in mice given a single injection of ll5mCd-labeled Cd complexes of
DMPS, DMSA and DTPA showed a high retention ofcadmium in the organisms after the
IV application ofCdDMPS and CdDMSA complexes.
Introduction
In previous papers (1-5) the effect of calcium
and zinc complexes of some aminopolycarboxylic
acids (APCA) in acute cadmium intoxication and
the effect ofthese compounds on the excretion and
distribution of cadmium were compared. The
most effective were CaDTPA and ZnDTPA (1,2,5),
though CdDTPA was neither the most inert ofthe
cadmium complexes of APCA used nor the least
toxic (3). It was also reported that N-acetyl-D,Lr
penicillamine had no antidotal activity in cad-
mium intoxication under the conditions used
(1,2). The effect ofdimercaprol was low (1,2).
The purpose ofthe present studies was to com-
pare the influence of CaDTPA and ZnDTPA on
the toxicity, retention and tissue distribution of
cadmium with the effects of some chelating
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agents containing -SH groups. In the light of
recent papers which deal with the use of mixed-
ligand chelates (6-9), the effect of the combina-
tion ofsome chelating agents was studied as well.
All the compounds were applied in acute experi-
ments in mice and rats. The chelating agents
were injected immediately after the cadmium in-
jection. This enabled study of the interaction of
this metal with chelating agents in the organism
before cadmium is firmly bound in the tissues.
Cadmium retention and distribution after the
application of some cadmium chelates was also
studied.
Materials and Methods
Male mice (SPF, Velaz Prague) (20-22 g) di-
vided into groups of n animals (see tables) were
used. In the experiment in which the chromato-
graphic analysis of urine was performed as well
as in the experiments irn which the effect of che-
lating agents on cadmium-inducedlipidperoxida-
tion was examined, male rats (SPF, Velaz, Pra-
gue), 130-150 g, were used.EYBL ET AL.
The following chemicals and drugs were used:
CdCl2
- 2.5 H20 (Lachema, puriss.gr.), D-penicil-
lamine (P) (Koch-Light Lab.), dimercaprol (DMP)
(BAL, Boots Pure Drug Co. Ltd.), CaNa3DTPA
andZnNa3DTPA (prepared in our laboratory from
Chel-DTPA, Geigy), CaNa2EDTA (Edtacal, Spofa)
and ZnNa2EDTA (prepared in our laboratory
from Chelaton 2, Lachema), dimercaptopropane-
sulfonic acid sodium salt (DMPS) (Dimaval, gift
from E. Heyl & Co., W. Berlin), meso-2,3-dimer-
captosuccinic acid (DMSA) prepared by us as so-
dium salt by dissolving in saline with equivalent
amount of NaHCO3 (gift from Fluka AG, Buchs,
Switzerland), diethyldithiocarbamate sodium salt
(Lachema, puriss.gr.).
In the cadmium excretion and distribution
study 115mCdCl2 (with carrier) (The Radiochemical
Centre, Amersham, England) was used. The ra-
dioactivity in the whole body and in various or-
gans after the IV application of 0.5 mg Cd2+/kg
(approximately 37 kBq per mouse) was measured
by using a scintillation spectrometer with Nal
(Tl) detector (10). The 115mCd-labeled complexes of
DMPS and DMSA were prepared by the addition
ofequivalent amounts ofthese compounds to the
1l5mCdCl2 saline solution. The results are ex-
pressed in percent ofapplied dose.
The same method as described previously (5,11)
was used for the chromatographic analysis of
urine.
The estimation of malondialdehyde as a prod-
uct oflipoperoxidation was performed in homoge-
nized liver of rats after 2 hr of incubation at pH
7.4 (12,13).
The effect of some chelating agents on the renal
tissue of cadmium-treated mice was determined.
Histopathological study after staining with he-
matoxylin and eosin and after a special histo-
chemical staining to determine the activity of
various intracellular enzymes was performed.
Survival ofmice was recorded at the end of 10
days. All results were statistically evaluated
(Student's t-test, x2 test, Fisher's test). The values
given are means + 95% limits.
Results
Influence ofChelating Agents on
Acute Toxicity ofCdCl, in Mice
The effect of P, DMP, CaEDTA, ZnEDTA,
CaDTPA and ZnDTPA on the cadmium toxicity
was compared (Table 1). In this experiment
CaDTPA and ZnDTPA appeared to be the most
effective antidotes. No protective effect was ob-
served afterthe administration ofZnEDTA and P.
In the next experiment, the influence of
CaDTPA, ZnDTPA, DMPS and DMSA injected in
doses corresponding to the various chelator:Cd
molar ratios was investigated (Table 2). CaDTPA
was the most effective agent ofthe chelators stud-
iedwhen lowdoses (1:1, 1:2) were used. No protec-
tive effect was observed with administration of
DMPS at these lower doses. High protection was
seen with DMSA at a dose corresponding to a
molar ratio of 5:1. After the application of this
higher dose the order of efficacy ofchelators was
found to be:
DMSA > CaDTPA > ZnDTPA > DMPS.
The result of experiments in which the protec-
tive effect ofDDC, CaDTPA and ZnDTPA in cad-
mium intoxication was compared is shown in
Table 3. DDC applied simultaneously or 2 hr after
the administration of cadmium was ineffective.
DTPA complexes provided protection only after
the simultaneous application with Cd.
Table 1. Effect ofchelating agents on survival ofmice injected with CdCl2.a
10 day
Group and survival Significance
treatment ratio % survival (group:group)
1 Cd only 1/20 5
2 Cd + D-penicillamine 3/20 15 NSt
3 Cd + dimercaprol 6/20 30 3:1*
4 Cd + CaEDTA 10/20 50 4:1t
4:6t
5 Cd + ZnEDTA 5/20 25 NS
6 Cd + CaDTPA 17/20 85 6:1t
6:4t
7 Cd + ZnDTPA 15/20 75 7:1t
aChelating agents were applied IP immediately following SC injection with CdCl2 * 2.5 H20 (20 mg/kg) at a chelator:Cd molar
ratio of25:1.
*p < 0.05.
tp < 0.01.
tNS = p > 0.05.
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Table 2. Effect ofchelating agents given in various doses on survival ofmice injected with CdCl2.a
10 day
Group and Molar ratio survival Significance
treatment chelator:Cd ratio % survival (group:group)
Experiment A
1 Cd only 0/20 0
2 Cd + CaDTPA 1:1 20/33 60.6 2:1t
3 Cd + ZnDTPA 1:1 2/33 6.06 NSt
4 Cd + DMSA 1:1 1/33 3.03 NSI:
S Cd + DMPS 1:1 0/33 0 NSt
Experiment B
6 Cd only 0/20 0
7 Cd + CaDTPA 2:1 16/20 80 7:6t
7:8t
7:9t
8 Cd + ZnDTPA 2:1 4/20 20 8:6*
9 Cd + DMSA 2:1 7/20 35 9:6t
9:7t
10 Cd + DMPS 2:1 0/15 0 NSt
Experiment C
11 Cd only 0
12 Cd + CaDTPA 5:1 27/33 81.82 12:11t
12:14*
13 Cd + ZnDTPA 5:1 20/33 60.67 13:11t
14 Cd + DMSA 5:1 33/33 100.0 14:11t
14:12*
15 Cd + DMPS 5:1 4/20 20.0 15:11*
aChelating agents were applied IP immediately following SC injection with CdCl2 -2.5 H20 (20 mg/kg) at various chelator:Cd
molar ratios.
*p
-- 0.05.
tp < 0.01.
tNS = p > 0.05.
Table 3. Effect ofthe combination ofchelating agents on survival ofmice which received CdCl2.a
10 day
Group and Molar ratio survival Significance
treatment chelator:Cd ratio % survival (group:group)
Experiment A
1 Cd only 0/20 0
2 Cd + ZnDTPA 2:1 12/20 60 2:1t
3 Cd + DMSA 2:1 13/20 65 3:1t
4 Cd + ZnDTPA + DMSA 1:1:1 19/20 95 4:2*
4:3*
Experiment B
S Cd only 0/20 0
6 Cd + CaDTPA 1:1 12/20 60 6:5t
7 Cd + DMSA 1:1 6/20 30 7:5*
8 Cd + CaDTPA + DMSA 0.5:0.5:1 10/20 50 8:6t
Experiment C
9 Cd only 0/20 0
10 Cd + ZnDTPA 2:1 4/20 20 10:9*
11 Cd + DMPS 2:1 0/20 100 NS1
12 Cd + DMPS + ZnDTPA 1:1:1 0/20 100 NSt
aChelating agents were applied IP immediately following SC injection with CdCl2 .2.5 H20 (20 mg/kg) at various chelator:Cd
molar ratios.
p<0.05.
tp<0.01.
tNS = p> 0.OS.
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Table 4. Effect ofsimultaneous and subsequent
administration ofsodium diethyldithiocarbamate
(DDC), CaDTPA and ZnDTPA on survival ofmice
receiving CdCI2.a
10 day
survival Significance
Group ratio % survival (group:group)
Experiment Ab
1 Cd only 0/15 0
2 DDC 1/15 6,7 NS
3 CaDTPA 13/15 86,7 3:1t
4 ZnDTPA 12/15 80,0 4:1t
Experiment Bc
1 Cd only 0+/15 0
2 DDC 0+/15 0 NS
3 CaDTPA 3+/15 20 NS
4 ZnDTPA 3+/15 20 NS
aChelating agents were applied IP at chelator:Cd molar
ratio of5:1 after SC administration ofCdCl2 2.5H20 (20 mg/
kg).
tp < 0.01.
bChelating agents applied immediately following cadmium
injection.
cChelating agents applied 2 hr after cadmium injection.
Table 4 shows the results ofthe experiment in
whichthe combination ofZnDTPA and DTPA was
administered. The additive effect of these two
chelating agents was demonstrated. This was
shown neither afterthe application ofZnDTPA +
DMPS nor after the injection of CaDTPA +
DMSA.
Influence ofChelating Agents and
Their Combinations on Retention
and Tissue Distribution ofCd in Mice
The effect of the chelating agents (P, DMPS,
CaDTPA) on the whole body retention and on the
content ofcadmium in various organs 48 hr after
the administration of CdCl2 is shown in Table 5.
No effect ofP on the cadmium retention was seen.
P as well as DMPS enhanced the amount ofcad-
mium retained in kidneys. CaDTPA was found to
be the most effective agent of the chelators used
in this experiment.
The results obtained in a similar experiment
are summarized in Table 6. The influence of
DMPS, DMSA, CaDTPA and ZnDTPA on the re-
Table 5. Effect ofchelating agents on total body burden and tissue content ofcadmium in mice
48 hr after the application ofCdCI2.a
Cd content oftissues, %b
Total body
Group and burden ofcadmium, Gastrointestinal
treatment %b Liver tract Kidneys
1 Cd only 78.50 ± 5.20 44.24 ± 3.20 7.10 ± 2.00 2.67 ± 0.70
2 Cd + D-penicillamine 80.70 ± 3.10 41.52 ± 2.63 6.20 ± 1.32 6.55 ± 1.70*
3 Cd + dimercaprol 48.30 ± 4.30 25.18 ± 1.91 1.94 ± 0.40 6.74 ± 0.93*
4 Cd + CaDTPA 12.70 + 1.43 7.74 ± 0.54 0.89 ± 0.28 0.64 ± 0.10*
aChelating agents were applied IP immediately following IV injection of ll5mCdCl2* 2.5 H20 (0.5 mg Cd/kg) at a chelator:Cd
molar ratio of50:1; n = 7 for each group.
bExpressed as % ofdose applied; values represent the mean ± 95% confidence limits.
*Significantly different from the control atp < 0.05.
Table 6. Effect ofchelating agents and their combination on total body burden and tissue content ofcadmium in mice
24 hr after the application ofCdCl2.a
Cd content oftissues, %b
Total body
Group and burden ofCd, Gastrointestinal
treatment %b Liver tract Kidneys
1 Cd only 89.57 ± 6.10 52.22 ± 5.63 10.25 ± 1.13 6.35 ± 0.91
2 Cd + DMPS IP 83.28 ± 7.80 41.67 ± 4.61* 7.34 ± 0.80* 8.83 ± 1.12
3 Cd + CaDTPA SC 33.38 ± 9.15* 17.33 ± 5.36* 3.41 ± 1.08* 3.87 ± 1.18*
4 Cd + CaDTPA SC + DMPS IP 24.50 ± 4.40* 13.52 ± 3.48* 2.40 ± 0.74* 2.75 ± 0.54*
5 Cd + DMSA IP 64.51 ± 7.21* 28.23 ± 4.64* 6.16 ± 1.07* 9.73 ± 1.32
6 Cd + CaDTPA SC + DMSA IP 22.01 ± 2.10* 9.52 ± 1.53* 2.30 ± 0.27* 3.21 ± 0.42*
7 Cd + ZnDTPA SC 44.73 ± 2.84* 24.82 ± 1.79* 5.12 ± 0.70* 4.05 ± 1.04*
aChelating agents were applied IP immediately following the IV injection ofll5mCdCl2 * 2.5 H20 (0.5 mg Cd/kg) at a chelator:Cd
molar ratio of10:1; n = 8 for all groups.
bExpressed as % ofdose applied; values represent the mean ± 95 confidence limits.
*Significantly different from the control atp < 0.05.
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Table 7. Effect ofchelating agents and their combination on total body burden and tissue content ofcadmium in mice
24 hr after the application ofCdCI2.a
Cd content oftissues, %b
Tbtal body
Molar ratio burden ofCd, Gastrointestinal
Group chelator:Cd %b Liver tract Kidneys
1 Cd only 88.12 ± 4.85 42.91 ± 5.27 11.15 ± 1.38 4.86 ± 1.49
2 Cd + DMSA SC 5:1 71.38 ± 8.34* 35.81 ± 6.10* 6.99 ± 1.51* 10.36 ± 3.47*
3 Cd + ZnDTPAIP 5:1 57.79 ± 7.13* 31.84 ± 7.27* 7.12 ± 1.73* 5.59 ± 0.97
4 Cd + ZnDTPA IP + DMSA SC 5:5:1 59.53 ± 6.77* 29.32 ± 4.54* 6.26 ± 1.37* 7.96 ± 2.24*
5 Cd + ZnDTPA IP 10:1 33.49 4.54* 16.50 ± 5.43* 3.91 ± 1.61* 3.01 ± 0.54*
6 Cd + CaDTPA IP 5:1 37.63 ± 9.77* 22.94 ± 6.93* 3.94 ± 1.13* 2.09 ± 1.09*
aChelating agents were applied immediately following the IV injection ofll5mCdCl2 * 2.5 H20 (0.5 mg Cd/kg) at various chelator:
Cd molar ratios; n = 7 for all groups.
bExpressed as % ofdose applied; values represent the mean ± 95% confidence limits.
*Significantly different from the control atp < 0.05.
tention and distribution of cadmium was deter-
mined. The most effective appeared to be
CaDTPA and the DMSA + CaDTPA combina-
tion. No increase in excretion of cadmium was
seen after DMPS. However, treatment with this
chelating agents significantly reduced the
amount ofcadmium found in the liver and gastro-
intestinal tract and increased the amount ofcad-
mium in kidneys and in other organs. Similarly,
all the compounds used decreased the amount of
cadmium in the liver and in the gastrointestinal
tract. DMSA increased the amount of cadmium
retained in the kidneys. The agents which de-
creased the content of cadmium in the kidneys
were CaDTPA, ZnDTPA and the combinations
CaDTPA + DMPS and CaDTPA + DMSA.
The results obtained in the experiment in
which the effect of the combination of ZnDTPA
and DMSA was examined are shown in Table 7.
The influence ofthis combination on the cadmium
retention was compared with the effects of single
agents given alone.
ZnDTPA applied at a dose of 5:1 was not effec-
tive. The effect of the combination ZnDTPA +
DMSA was not better than that of ZnDTPA.
DMSA increased the content of cadmium in the
kidneys in all cases. The effect of CaDTPA (5:1)
was the same as that of ZnDTPA (10:1). The
amount of cadmium retained in the liver was
decreased after the application ofthe compounds.
Another experiment demonstrated (Table 8)
that the combination ofZnDTPA + DMSA (5:5:1)
is more effective than DMSA (10:1). However, the
effect ofthat combination did not reach the effect
ofZnDTPA (10:1). After the application ofDMSA
(either alone or in combination) the content of
cadmium in the kidneys was elevated.
Chromatographic Analysis of Rat
Urine after Administration ofCdCl,
and Chelating Agents
In the urine of rats given CdCl2 * 2.5 H20 (10
mg/kg, SC) and treated with CaDTPA, ZnDTPA,
DMSA (5:1) or with the combination of CaDTPA
+ DMSA and ZnDTPA + DMSA (5:5:1) the Cd
complexes of DMSA and DTPA were detected by
paper chromatography. The properties of
CdDMSA complexes are different from those of
CdDTPA. An extremely slow flow rate of
Table 8. Effect ofchelating agents and their combination on total body burden and tissue content ofcadmium in mice
24 hr after the application ofCdCl2.a
Cd content oftissues, %b
Ibtal body
Molar ratio burden ofCd, Gastrointestinal
Group chelator:Cd %b Liver tract Kidneys
1 Cd only 88.12 ± 4.85 42.91 ± 5.27 11.15 ± 1.38 4.86 ± 1.49
2 Cd + ZnDTPA IP 10:1 33.45 ± 2.36* 16.50 ± 5.50* 3.91 ± 2.30* 3.01 ± 0.54*
3 Cd + DMSA SC 10:1 60.81 ± 2.73* 23.11 ± 3.81* 4.80 ± 0.70* 10.53 ± 1.99
4 Cd + ZnDTPA IP + DMSA SC 5:5:1 50.36 ± 4.66* 17.84 ± 5.10* 5.62 ± 0.50* 8.04 ± 0.66*
aChelating agents were applied immediately following the IV injection of1l5mCdCl2. 2.5 H20 (0.5 mg/kg) at various chelator: Cd
molar ratios; n = 8 for all groups.
bExpressed as % ofdose applied; values represent the mean ± 95% confidence limits.
*Significantly different from the control atp < 0.05.
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jig malondialdehyde/g tissueb
Control Cd Cd + CaDTPA Cd + ZnDTPA Cd + DMSA
38.7 ± 5.7 89.8 ± 9.8* 33.6 ± 4.8 31.4 ± 9.8 46.0 ± 13.3
n = 8 n = 5 n = 8 n = 8 n = 8
aChelating agents were applied IP immediately following the SC injection ofCdCl2
- 2.5 H20 (7.5 mg/kg) at a chelator: Cd molar
ration of5:1.
bMean values ± 95% confidence limits.
*Significantly different from the control atp < 0.05.
CdDMSA was found. The independent formation
ofCdDTPA in the presence ofDMSA was demon-
strated. The formation of mixed ligand chelates
was not proved.
Influence ofChelating Agents on
Lipid Peroxidation
The influence ofchelating agents on cadmium-
induced lipidperoxidation inkidneys ofrats 48 hr
after administration of Cd shows that the lipid
peroxidation in kidney homogenates is signifi-
cantly elevated. All the chelating agents used
(CaDTPA, ZnDTPA, DMSA) were effective in pre-
venting cadmium-induced lipid peroxidation (Ta-
ble 9).
Histopathological Examination of
Mouse Renal Tissue
In a preliminary experiment, mice were in-
jected with CdCl2 * 2.5 H20 at in a dose of5 mg/kg
SC alone or inthe combination withthe chelating
agents CaDTPA, ZnDTPA or DMSA (5:1 IP). The
kidneys were removed 48 hr after the treatment.
No histopathological changes were found in any
case when the hematoxylin and eosin staining
was used. A slight reduction ofthe activity ofacid
phosphatase in cells of the tubules was demon-
strated after the application of cadmium and
CaDTPA. No changes in the activity ofglutamate
dehydrogenase, a-glycerol phosphate dehydro-
genase and nicotinicadenine dinucleotide reduc-
tase were found.
Retention and Tissue Distribution
ofCd after Administration
ofCd Chelates
In this experiment, 115mCdCl2 and 115mCd-la-
beled cadmium chelates were administered IV to
mice. The results are shown in Table 10. The
highest cadmium excretion was found after the
injection of CdDTPA. The total body burden of
cadmium after the administration ofCd (DMPS)1
and CdDMSA complexes did not differ signifi-
cantly from that estimated after the administra-
tion of CdCl2. The whole body retention of cad-
mium after the administration of Cd (DMPS)3
was lower than that ofthe controls. The amount
ofcadmium retained in the kidneys was elevated
aftertheinjectionofCd(DMPS)3,Cd(DMSA), and
Cd(DMSA)3.
Discussion and Conclusions
The results confirm our earlier findings with
regard to the efficiency ofCaDTPA and ZnDTPA
in acute cadmium intoxication (5). DMSA was
more effective than CaDTPA when applied in
Table 10. Total body burden and tissue content ofcadmium in mice 24 hr after the
application ofCdCl2 and Cd chelates.a
Tissue content ofCd, %b
Tbtal body
Group and burden ofCd, Gastrointestinal
treatment %b Liver tract Kidneys
1 CdCl2 94.30 ± 4.47 59.31 ± 6.38 9.58 ± 1.48 6.07 ± 1.02
2 Cd(DMPS), 93.02 + 7.02 54.07 ± 8.58 9.33 ± 2.36 7.37 ± 1.32
3 Cd(DMPS)3 82.47 ± 5.02 38.59 ± 2.38* 8.13 ± 1.47 10.87 ± 1.91
4 Cd(DMSA), 95.75 + 5.02* 55.46 ± 6.92 6.50 ± 1.71* 7.63 ± 1.55*
5 Cd(DMSA)3 95.89 ± 5.81 53.94 ± 8.23 7.24 ± 1.16* 8.14 ± 1.43*
6 CdDTPA 66.31 ± 6.87* 37.53 ± 3.89* 6.39 ± 1.28 5.92 + 1.51
aThe ll5mCdCl2 and ll5mCd chelates were applied IV at a dose of0.5 mg Cd/kg; n = 8 for all groups.
bExpressed as % ofdose applied; values represent the mean ± 95% confidence limits.
*Significantly different from the control atp < 0.05.
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higherdoses. However, the contentofcadmium in
the kidneys was elevated after the application of
this agent. Ourresults are in agreement with the
finding ofother authors (8,9,14,15). However, we
were not able to demonstrate a positive effect of
DMSA on the cadmium content in the kidneys
(14). All the chelating agents containing sulfhy-
dryl groups increase the cadmium content in the
kidneys.
We were unable to confirm the increase in the
effectiveness of DDC as an antidote when treat-
ment is delayed after administration ofcadmium
(16,17). The effectiveness ofthe DTPA complexes
decreases with increasing interval between the
injection of cadmium and these agents. This
result is in agreement with our earlier findings
(4).
The mobilizing andprotective effectofZnDTPA
in cadmium intoxication is based predominantly
on the kinetic lability of this complex which fa-
cilitates the exchange ofthe metal bound in che-
late (pseudoisotopic exchange) (5).
Neither the formation ofmixed ligand chelates
in vivo nor the potentiation of the effectiveness
after the simultaneous application of two chela-
torswas shown. Onlythe combination ofZnDTPA
+ DMSA in acute cadmium intoxication im-
proved the effect achieved with one chelator
alone.
There is considerable speculation and contro-
versy regarding the mode oftoxic action ofheavy
metals. One mechanism suggested isthattoxicity
of some heavy metals may be mediated through
peroxidation of membrane lipids. We have dem-
onstrated the cadmium-induced lipid peroxida-
tion in liver of rats. This effect of cadmium was
vitiated by the pretreatment with zinc chloride
(13). The protective effect ofchelating agents on
the cadmium-induced lipid peroxidation in kid-
neys was demonstrated.
Even though the amount of cadmium in kid-
neys is enhanced due to DMSA in mice, the cad-
mium-induced lipid peroxidation in kidney tissue
was decreased after the administration of cad-
mium and DMSA in rats. The properties of the
CdDMSA complex formed in course ofthe detoxi-
cation ofcadmium merit further examination.
The protective effect of DMSA in cadmium-
induced lipid peroxidation is probably caused by
the binding ofcadmium. However, a direct effect
of DMSA on the lipid peroxidation is not ex-
cluded.
The results ofour experiments form a basis for
the selection of agents which might be used in
further studies of the mobilization of cadmium
from old deposits in the organism.
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